comparemela.com

Latest Breaking News On - Biopharmaceutical product development - Page 1 : comparemela.com

Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System

ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development

GreenLight Biosciences Welcomes Amin Khan As Chief Scientific Officer, Human Health

GreenLight Biosciences Welcomes Amin Khan As Chief Scientific Officer, Human Health BOSTON, April 28, 2021 /PRNewswire/ GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health, today announced the appointment of Amin Khan as the company s Chief Scientific Officer, Human Health. Khan joins GreenLight from GSK s Vaccines business where he was a member of their R&D leadership team. He headed their Technical R&D organization, and recently led Vaccines R&D Acceleration, where he was responsible for end-to-end accelerated development of the vaccine portfolio. GreenLight aims to address humanity s greatest challenges, from producing vaccines to protecting bees, said Andrey Zarur, CEO of GreenLight Biosciences. Amin brings deep experience developing and launching vaccines, which will be critical to our mission to democratize healthcare.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.